Introduction to Semaglutide
Semaglutide is an injectable medication used to improve glycemic control in adults with type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps lower blood sugar levels by stimulating insulin production and reducing glucagon secretion.
Semaglutide was approved by the FDA in 2017 under the brand names Ozempic® and Rybelsus®. It is considered more effective than many other diabetes medications, with the additional benefits of promoting weight loss and cardiovascular protection.
At Thrive HRT, we provide individualized Semaglutide therapy to help patients better manage their diabetes and associated health conditions. In this comprehensive guide, we will cover all the key information you need to know about Semaglutide treatment.